H.PIO Co., Ltd. (KOSDAQ:357230)
South Korea · Delayed Price · Currency is KRW 2,125.00
-25.00 (-1.16%)
At close: Oct 2, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 87.34 billion as of October 2, 2026. Its market cap has decreased by -22.77% in one year.
Market Cap
87.34B
Enterprise Value
106.69B
Revenue
269.63B
Ranking
n/a
PE Ratio
9.72
Stock Price
2,125.00
ChartMarket Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 87.34B, a decrease of -73.85%. That is a compound annual growth rate of -22.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 87.34B | -12.56% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 110.11B |
| High Tech Pharm | 108.03B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 95.70B |
| KOREA PHARMA | 95.11B |
| DongKoo Bio & Pharma | 95.05B |
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 84.53B |
| Daehan Nupharm | 78.46B |